Close Menu

NEW YORK (GenomeWeb) – This month's annual meeting of the American Society of Clinical Oncology hosted numerous updates on the use of liquid biopsy tests to monitor cancer patients either after surgery or during treatment with certain drugs. Highlights included abstracts on bespoke or patient-specific platforms, as well as more generalized single-mutation and genome-wide assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.